Figure 3From: Homopharma: A new concept for exploring the molecular binding mechanisms and drug repurposingThe pharma-interface and Homopharma groups of thymidine kinase and deoxythymidine complex. (A) The pharma-interface of thymidine kinase (TK) and deoxythymidine (THM) complex consists of five pharma-motifs. The protein-compound interactions were grouped into four Homopharma groups based on interaction similarity scores. (B) The superimposed structures of Homopharma 1 and conserved interacting residues (residue numbering of PDB code: 1OI3). (C) The superimposed structures of Homopharma 2 and conserved interacting residues (residue numbering of PDB code: 1KIM).Back to article page